← Back

Alzamend Neuro, Inc.

ALZN
$1.37-0.72%

SEC Filings

Recommended10-K · Jul 22, 2026

Not sure where to start? This is Alzamend Neuro, Inc.'s most recent annual report. Start with its AI summary.

Summarize this filing

Showing filings since Sep 13, 2021. Full history on SEC EDGAR